• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of envhperEnvironmental Health PerspectivesBrowse ArticlesAbout EHPGeneral InformationAuthorsMediaProgramsPartnerships
Environ Health Perspect. Sep 2002; 110(9): 853–858.
PMCID: PMC1240982
Research Article

Linking dioxins to diabetes: epidemiology and biologic plausibility.

Abstract

Recent epidemiologic studies suggest a possible association between dioxin-like compounds (DLCs) and diabetes in human populations, although experimental links between DLCs and diabetes are lacking. The public health significance of such an association is that all populations are exposed to small but measurable levels of DLCs, chronic low-dose exposure to which may hasten the onset of adult-onset diabetes in susceptible individuals. In this article, we review the epidemiologic studies and propose biologically plausible connections between dioxins and diabetes. Specifically, we suggest that aryl hydrocarbon (Ah) receptor functions may antagonize peroxisome proliferator-activated receptor (PPAR) functions, and hence that the Ah receptor may promote diabetogenesis through a mechanism of PPAR antagonism.

Full Text

The Full Text of this article is available as a PDF (530K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Van den Berg M, Birnbaum L, Bosveld AT, Brunström B, Cook P, Feeley M, Giesy JP, Hanberg A, Hasegawa R, Kennedy SW, et al. Toxic equivalency factors (TEFs) for PCBs, PCDDs, PCDFs for humans and wildlife. Environ Health Perspect. 1998 Dec;106(12):775–792. [PMC free article] [PubMed]
  • Higginbotham GR, Huang A, Firestone D, Verrett J, Ress J, Campbell AD. Chemical and toxicological evaluations of isolated and synthetic chloro derivatives of dibenzo-p-dioxin. Nature. 1968 Nov 16;220(5168):702–703. [PubMed]
  • Kimbrough RD. Toxicity of chlorinated hydrocarbons and related compounds. A review including chlorinated dibenzodioxins and chlorinated dibenzofurans. Arch Environ Health. 1972 Aug;25(2):125–131. [PubMed]
  • Schwetz BA, Norris JM, Sparschu GL, Rowe UK, Gehring PJ, Emerson JL, Gerbig CG. Toxicology of chlorinated dibenzo-p-dioxins. Environ Health Perspect. 1973 Sep;5:87–99. [PMC free article] [PubMed]
  • Dragan YP, Schrenk D. Animal studies addressing the carcinogenicity of TCDD (or related compounds) with an emphasis on tumour promotion. Food Addit Contam. 2000 Apr;17(4):289–302. [PubMed]
  • Fischer B. Receptor-mediated effects of chlorinated hydrocarbons. Andrologia. 2000 Sep;32(4-5):279–283. [PubMed]
  • Yonemoto J. The effects of dioxin on reproduction and development. Ind Health. 2000 Jul;38(3):259–268. [PubMed]
  • Leung HW, Murray FJ, Paustenbach DJ. A proposed occupational exposure limit for 2,3,7,8-tetrachlorodibenzo-p-dioxin. Am Ind Hyg Assoc J. 1988 Sep;49(9):466–474. [PubMed]
  • Cooney CM. How serious is dioxin's cancer risk? Environ Sci Technol. 2001 May 1;35(9):180A–181A. [PubMed]
  • Granner DK, O'Brien RM. Molecular physiology and genetics of NIDDM. Importance of metabolic staging. Diabetes Care. 1992 Mar;15(3):369–395. [PubMed]
  • Felber JP, Golay A. Regulation of nutrient metabolism and energy expenditure. Metabolism. 1995 Feb;44(2 Suppl 2):4–9. [PubMed]
  • Viluksela M, Unkila M, Pohjanvirta R, Tuomisto JT, Stahl BU, Rozman KK, Tuomisto J. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on liver phosphoenolpyruvate carboxykinase (PEPCK) activity, glucose homeostasis and plasma amino acid concentrations in the most TCDD-susceptible and the most TCDD-resistant rat strains. Arch Toxicol. 1999 Aug;73(6):323–336. [PubMed]
  • Rozman KK. Search for the mechanism of toxicity of dioxins. A lesson in toxicology. Exp Toxicol Pathol. 1992 Dec;44(8):473–480. [PubMed]
  • Zober A, Ott MG, Messerer P. Morbidity follow up study of BASF employees exposed to 2,3,7, 8-tetrachlorodibenzo-p-dioxin (TCDD) after a 1953 chemical reactor incident. Occup Environ Med. 1994 Jul;51(7):479–486. [PMC free article] [PubMed]
  • Sweeney MH, Calvert GM, Egeland GA, Fingerhut MA, Halperin WE, Piacitelli LA. Review and update of the results of the NIOSH medical study of workers exposed to chemicals contaminated with 2,3,7,8-tetrachlorodibenzodioxin. Teratog Carcinog Mutagen. 1997;17(4-5):241–247. [PubMed]
  • Calvert GM, Sweeney MH, Deddens J, Wall DK. Evaluation of diabetes mellitus, serum glucose, and thyroid function among United States workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Occup Environ Med. 1999 Apr;56(4):270–276. [PMC free article] [PubMed]
  • Bertazzi PA, Bernucci I, Brambilla G, Consonni D, Pesatori AC. The Seveso studies on early and long-term effects of dioxin exposure: a review. Environ Health Perspect. 1998 Apr;106 (Suppl 2):625–633. [PMC free article] [PubMed]
  • Henriksen GL, Ketchum NS, Michalek JE, Swaby JA. Serum dioxin and diabetes mellitus in veterans of Operation Ranch Hand. Epidemiology. 1997 May;8(3):252–258. [PubMed]
  • Michalek JE, Akhtar FZ, Kiel JL. Serum dioxin, insulin, fasting glucose, and sex hormone-binding globulin in veterans of Operation Ranch Hand. J Clin Endocrinol Metab. 1999 May;84(5):1540–1543. [PubMed]
  • Longnecker MP, Michalek JE. Serum dioxin level in relation to diabetes mellitus among Air Force veterans with background levels of exposure. Epidemiology. 2000 Jan;11(1):44–48. [PubMed]
  • Michalek JE, Tripathi RC, Caudill SP, Pirkle JL. Investigation of TCDD half-life heterogeneity in veterans of Operation Ranch Hand. J Toxicol Environ Health. 1992 Jan;35(1):29–38. [PubMed]
  • Geyer HJ, Scheunert I, Rapp K, Gebefügi I, Steinberg C, Kettrup A. The relevance of fat content in toxicity of lipophilic chemicals to terrestrial animals with special reference to dieldrin and 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Ecotoxicol Environ Saf. 1993 Aug;26(1):45–60. [PubMed]
  • Hu K, Bunce NJ. Metabolism of polychlorinated dibenzo-p-dioxins and related dioxin-like compounds. J Toxicol Environ Health B Crit Rev. 1999 Apr-Jun;2(2):183–210. [PubMed]
  • Cranmer M, Louie S, Kennedy RH, Kern PA, Fonseca VA. Exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is associated with hyperinsulinemia and insulin resistance. Toxicol Sci. 2000 Aug;56(2):431–436. [PubMed]
  • Tritscher AM, Clark GC, Sewall C, Sills RC, Maronpot R, Lucier GW. Persistence of TCDD-induced hepatic cell proliferation and growth of enzyme altered foci after chronic exposure followed by cessation of treatment in DEN initiated female rats. Carcinogenesis. 1995 Nov;16(11):2807–2811. [PubMed]
  • Rier SE, Coe CL, Lemieux AM, Martin DC, Morris R, Lucier GW, Clark GC. Increased tumor necrosis factor-alpha production by peripheral blood leukocytes from TCDD-exposed rhesus monkeys. Toxicol Sci. 2001 Apr;60(2):327–337. [PubMed]
  • Wilson CL, Safe S. Mechanisms of ligand-induced aryl hydrocarbon receptor-mediated biochemical and toxic responses. Toxicol Pathol. 1998 Sep-Oct;26(5):657–671. [PubMed]
  • Tian Y, Ke S, Denison MS, Rabson AB, Gallo MA. Ah receptor and NF-kappaB interactions, a potential mechanism for dioxin toxicity. J Biol Chem. 1999 Jan 1;274(1):510–515. [PubMed]
  • Puga A, Barnes SJ, Dalton TP, Chang C y, Knudsen ES, Maier MA. Aromatic hydrocarbon receptor interaction with the retinoblastoma protein potentiates repression of E2F-dependent transcription and cell cycle arrest. J Biol Chem. 2000 Jan 28;275(4):2943–2950. [PubMed]
  • Nguyen TA, Hoivik D, Lee JE, Safe S. Interactions of nuclear receptor coactivator/corepressor proteins with the aryl hydrocarbon receptor complex. Arch Biochem Biophys. 1999 Jul 15;367(2):250–257. [PubMed]
  • Clay CE, Namen AM, Fonteh AN, Atsumi G, High KP, Chilton FH. 15-deoxy-Delta(12,14)PGJ(2) induces diverse biological responses via PPARgamma activation in cancer cells. Prostaglandins Other Lipid Mediat. 2000 Jun;62(1):23–32. [PubMed]
  • Greene ME, Pitts J, McCarville MA, Wang XS, Newport JA, Edelstein C, Lee F, Ghosh S, Chu S. PPARgamma: observations in the hematopoietic system. Prostaglandins Other Lipid Mediat. 2000 Jun;62(1):45–73. [PubMed]
  • Shimaya A, Kurosaki E, Shioduka K, Nakano R, Shibasaki M, Shikama H. YM268 increases the glucose uptake, cell differentiation, and mRNA expression of glucose transporter in 3T3-L1 adipocytes. Horm Metab Res. 1998 Sep;30(9):543–548. [PubMed]
  • Singh Ahuja H, Liu S, Crombie DL, Boehm M, Leibowitz MD, Heyman RA, Depre C, Nagy L, Tontonoz P, Davies PJ. Differential effects of rexinoids and thiazolidinediones on metabolic gene expression in diabetic rodents. Mol Pharmacol. 2001 Apr;59(4):765–773. [PubMed]
  • Alexander DL, Ganem LG, Fernandez-Salguero P, Gonzalez F, Jefcoate CR. Aryl-hydrocarbon receptor is an inhibitory regulator of lipid synthesis and of commitment to adipogenesis. J Cell Sci. 1998 Nov;111(Pt 22):3311–3322. [PubMed]
  • Enan E, Liu PC, Matsumura F. TCDD (2,3,7,8-tetrachlorodibenzo-P-dioxin) causes reduction in glucose uptake through glucose transporters on the plasma membrane of the guinea pig adipocyte. J Environ Sci Health B. 1992 Oct;27(5):495–510. [PubMed]
  • Liu PC, Matsumura F. Differential effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on the "adipose- type" and "brain-type" glucose transporters in mice. Mol Pharmacol. 1995 Jan;47(1):65–73. [PubMed]
  • Simpson F, Whitehead JP, James DE. GLUT4--at the cross roads between membrane trafficking and signal transduction. Traffic. 2001 Jan;2(1):2–11. [PubMed]
  • Murphy GJ, Holder JC. PPAR-gamma agonists: therapeutic role in diabetes, inflammation and cancer. Trends Pharmacol Sci. 2000 Dec;21(12):469–474. [PubMed]
  • Schoonjans K, Auwerx J. Thiazolidinediones: an update. Lancet. 2000 Mar 18;355(9208):1008–1010. [PubMed]
  • Komers R, Vrána A. Thiazolidinediones--tools for the research of metabolic syndrome X. Physiol Res. 1998;47(4):215–225. [PubMed]
  • Suzuki A, Yasuno T, Kojo H, Hirosumi J, Mutoh S, Notsu Y. Alteration in expression profiles of a series of diabetes-related genes in db/db mice following treatment with thiazolidinediones. Jpn J Pharmacol. 2000 Oct;84(2):113–123. [PubMed]
  • Fernández-Real JM, Ricart W. Insulin resistance and inflammation in an evolutionary perspective: the contribution of cytokine genotype/phenotype to thriftiness. Diabetologia. 1999 Nov;42(11):1367–1374. [PubMed]
  • Taylor MJ, Lucier GW, Mahler JF, Thompson M, Lockhart AC, Clark GC. Inhibition of acute TCDD toxicity by treatment with anti-tumor necrosis factor antibody or dexamethasone. Toxicol Appl Pharmacol. 1992 Nov;117(1):126–132. [PubMed]
  • Fan F, Yan B, Wood G, Viluksela M, Rozman KK. Cytokines (IL-1beta and TNFalpha) in relation to biochemical and immunological effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in rats. Toxicology. 1997 Jan 15;116(1-3):9–16. [PubMed]
  • Moos AB, Oughton JA, Kerkvliet NI. The effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on tumor necrosis factor (TNF) production by peritoneal cells. Toxicol Lett. 1997 Feb 7;90(2-3):145–153. [PubMed]
  • Yang JH, Vogel C, Abel J. A malignant transformation of human cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin exhibits altered expressions of growth regulatory factors. Carcinogenesis. 1999 Jan;20(1):13–18. [PubMed]
  • Heery DM, Hoare S, Hussain S, Parker MG, Sheppard H. Core LXXLL motif sequences in CREB-binding protein, SRC1, and RIP140 define affinity and selectivity for steroid and retinoid receptors. J Biol Chem. 2001 Mar 2;276(9):6695–6702. [PubMed]
  • Nolte RT, Wisely GB, Westin S, Cobb JE, Lambert MH, Kurokawa R, Rosenfeld MG, Willson TM, Glass CK, Milburn MV. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma. Nature. 1998 Sep 10;395(6698):137–143. [PubMed]
  • Webb P, Anderson CM, Valentine C, Nguyen P, Marimuthu A, West BL, Baxter JD, Kushner PJ. The nuclear receptor corepressor (N-CoR) contains three isoleucine motifs (I/LXXII) that serve as receptor interaction domains (IDs). Mol Endocrinol. 2000 Dec;14(12):1976–1985. [PubMed]
  • Ren Y, Behre E, Ren Z, Zhang J, Wang Q, Fondell JD. Specific structural motifs determine TRAP220 interactions with nuclear hormone receptors. Mol Cell Biol. 2000 Aug;20(15):5433–5446. [PMC free article] [PubMed]
  • Ko L, Cardona GR, Chin WW. Thyroid hormone receptor-binding protein, an LXXLL motif-containing protein, functions as a general coactivator. Proc Natl Acad Sci U S A. 2000 May 23;97(11):6212–6217. [PMC free article] [PubMed]
  • Zhu Y, Kan L, Qi C, Kanwar YS, Yeldandi AV, Rao MS, Reddy JK. Isolation and characterization of peroxisome proliferator-activated receptor (PPAR) interacting protein (PRIP) as a coactivator for PPAR. J Biol Chem. 2000 May 5;275(18):13510–13516. [PubMed]
  • Johansson L, Båvner A, Thomsen JS, Färnegårdh M, Gustafsson JA, Treuter E. The orphan nuclear receptor SHP utilizes conserved LXXLL-related motifs for interactions with ligand-activated estrogen receptors. Mol Cell Biol. 2000 Feb;20(4):1124–1133. [PMC free article] [PubMed]
  • Zhang H, Thomsen JS, Johansson L, Gustafsson JA, Treuter E. DAX-1 functions as an LXXLL-containing corepressor for activated estrogen receptors. J Biol Chem. 2000 Dec 22;275(51):39855–39859. [PubMed]
  • Kumar MB, Tarpey RW, Perdew GH. Differential recruitment of coactivator RIP140 by Ah and estrogen receptors. Absence of a role for LXXLL motifs. J Biol Chem. 1999 Aug 6;274(32):22155–22164. [PubMed]
  • Devine JH, Eubank DW, Clouthier DE, Tontonoz P, Spiegelman BM, Hammer RE, Beale EG. Adipose expression of the phosphoenolpyruvate carboxykinase promoter requires peroxisome proliferator-activated receptor gamma and 9-cis-retinoic acid receptor binding to an adipocyte-specific enhancer in vivo. J Biol Chem. 1999 May 7;274(19):13604–13612. [PubMed]
  • Cassuto H, Aran A, Cohen H, Eisenberger CL, Reshef L. Repression and activation of transcription of phosphoenolpyruvate carboxykinase gene during liver development. FEBS Lett. 1999 Sep 3;457(3):441–444. [PubMed]
  • Tontonoz P, Hu E, Devine J, Beale EG, Spiegelman BM. PPAR gamma 2 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene. Mol Cell Biol. 1995 Jan;15(1):351–357. [PMC free article] [PubMed]
  • Viluksela M, Stahl BU, Birnbaum LS, Rozman KK. Subchronic/chronic toxicity of a mixture of four chlorinated dibenzo-p-dioxins in rats. II. Biochemical effects. Toxicol Appl Pharmacol. 1998 Jul;151(1):70–78. [PubMed]
  • Brewster DW, Bombick DW, Matsumura F. Rabbit serum hypertriglyceridemia after administration of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). J Toxicol Environ Health. 1988;25(4):495–507. [PubMed]
  • Kersten S, Wahli W. Peroxisome proliferator activated receptor agonists. EXS. 2000;89:141–151. [PubMed]
  • Best JD, O'Neal DN. Diabetic dyslipidaemia: current treatment recommendations. Drugs. 2000 May;59(5):1101–1111. [PubMed]
  • Lai ZW, Hundeiker C, Gleichmann E, Esser C. Cytokine gene expression during ontogeny in murine thymus on activation of the aryl hydrocarbon receptor by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Mol Pharmacol. 1997 Jul;52(1):30–37. [PubMed]
  • Calleja C, Eeckhoutte C, Larrieu G, Dupuy J, Pineau T, Galtier P. Differential effects of interleukin-1 beta, interleukin-2, and interferon-gamma on the inducible expression of CYP 1A1 and CYP 1A2 in cultured rabbit hepatocytes. Biochem Biophys Res Commun. 1997 Oct 9;239(1):273–278. [PubMed]
  • Charles GD, Shiverick KT. 2,3,7,8-Tetrachlorodibenzo-p-dioxin increases mRNA levels for interleukin-1beta, urokinase plasminogen activator, and tumor necrosis factor-alpha in human uterine endometrial adenocarcinoma RL95-2 cells. Biochem Biophys Res Commun. 1997 Sep 18;238(2):338–342. [PubMed]
  • Vainio H, Linnainmaa K, Kähönen M, Nickels J, Hietanen E, Marniemi J, Peltonen P. Hypolipidemia and peroxisome proliferation induced by phenoxyacetic acid herbicides in rats. Biochem Pharmacol. 1983 Sep 15;32(18):2775–2779. [PubMed]
  • Wielandt AM, Vollrath V, Manzano M, Miranda S, Accatino L, Chianale J. Induction of the multispecific organic anion transporter (cMoat/mrp2) gene and biliary glutathione secretion by the herbicide 2,4,5-trichlorophenoxyacetic acid in the mouse liver. Biochem J. 1999 Jul 1;341(Pt 1):105–111. [PMC free article] [PubMed]
  • Maloney EK, Waxman DJ. trans-Activation of PPARalpha and PPARgamma by structurally diverse environmental chemicals. Toxicol Appl Pharmacol. 1999 Dec 1;161(2):209–218. [PubMed]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Science

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

  • PubMed
    PubMed
    PubMed citations for these articles
  • Substance
    Substance
    PubChem Substance links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...